Miltefosine

CHEMBL125 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

407.6 g/mol

LogP

6.7

Phase

4

This oral medication disrupts the cell membranes of parasites and certain cancer cells, leading to their death. It is the first oral treatment approved for leishmaniasis, a parasitic infection transmitted by sandfly bites.

Berat Molekul

407,6000 g/mol

LogP

6,70

TPSA

58,60 Å²

Lipinski RO5

Lulus

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C

InChI

InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3

Molecular Formula

C21H46NO4P

HBD / HBA

- / 4

Ikatan yang Dapat Dirotasi

20

Atom Berat

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This oral medication disrupts the cell membranes of parasites and certain cancer cells, leading to their death. It is the first oral treatment approved for leishmaniasis, a parasitic infection transmitted by sandfly bites.

Yes, Miltefosine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL125. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3599. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Miltefosine di PillFYI

Struktur

Data Cepat

Rumus: C21H46NO4P
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.